AcquisitionOther
Sanofi acquired Blueprint Medicines Corporation
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Sanofi -> Blueprint Medicines Corporation · $9.1 billion
Acquire biopharmaceutical company specializing in rare immunological disease with approved medicine Ayvakit/Ayvakyt.
Open source record (SEC) ↗